Healthcare Finance News July 20, 2022
Susan Morse

Equitable Breakthroughs in Medicine Development will get more underrepresented patients involved in the R&D of medical treatments.

The Pharmaceutical Research and Manufacturers of America is funding a clinical trial initiative to enhance diversity, which has been lacking in the development of new drugs.

The initial $10 million grant will fund an 18-month pilot at ten community sites located in the southern United States.

PhRMA is collaborating on the Equitable Breakthroughs in Medicine Development with the Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center at Morehouse School of Medicine and Vanderbilt University Medical Center.


Clinical trials have long been challenged in getting enough participation, particularly in getting a diverse population.


Today's Sponsors

Oliver Wyman
Upfront Healthcare

Today's Sponsors


Today's Sponsor


Topics: Biotechnology, Clinical Trials, Equity/SDOH, Healthcare System, Pharma, Pharma / Biotech, Trends
Cancer treatment: Drug candidate shows promise in clinical trial
Effect of pharmacist email alerts on concurrent prescribing of opioids and benzodiazepines by prescribers and primary care managers: a randomized clinical trial.
AI in Clinical Trials Market Could be Worth $4.8 billion by 2027
Bezyl partners with Scout Clinical and Atlas to upgrade mental health app support for clinical trial participants
Why people with breast cancer should ask their health care team about clinical trials